Literature DB >> 30903511

Biochemical, machine learning and molecular approaches for the differential diagnosis of Mucopolysaccharidoses.

Srilatha Kadali1,2, Shaik Mohammad Naushad2, Akella Radha Rama Devi3, Vijaya Lakshmi Bodiga4.   

Abstract

This study was aimed to construct classification and regression tree (CART) model of glycosaminoglycans (GAGs) for the differential diagnosis of Mucopolysaccharidoses (MPS). Two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used for the qualitative and quantitative analysis of GAGs. Specific enzyme assays and targeted gene sequencing were performed to confirm the diagnosis. Machine learning tools were used to develop CART model based on GAG profile. Qualitative and quantitative CART models showed 96.3% and 98.3% accuracy, respectively, in the differential diagnosis of MPS. The thresholds of different GAGs diagnostic of specific MPS types were established. In 60 MPS positive cases, 46 different mutations were identified in six specific genes. Among 31 different mutations identified in IDUA, nine were nonsense mutations and two were gross deletions while the remaining were missense mutations. In IDS gene, four missense, two frameshift, and one deletion were identified. In NAGLU gene, c.1693C > T and c.1914_1914insT were the most common mutations. Two ARSB, one case each of SGSH and GALNS mutations were observed. LC-MS/MS-based GAG pattern showed higher accuracy in the differential diagnosis of MPS. The mutation spectrum of MPS, specifically in IDUA and IDS genes, is highly heterogeneous among the cases studied.

Entities:  

Keywords:  CART model; Glycosaminoglycans; LC–MS/MS; Machine learning tools; Mucopolysaccharidoses; Mutation analysis

Mesh:

Substances:

Year:  2019        PMID: 30903511     DOI: 10.1007/s11010-019-03527-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  4 in total

1.  Whole genome sequencing for mutation discovery in a single case of lysosomal storage disease (MPS type 1) in the dog.

Authors:  Tamer A Mansour; Kevin D Woolard; Karen L Vernau; Devin M Ancona; Sara M Thomasy; Lionel Sebbag; Bret A Moore; Marguerite F Knipe; Haitham A Seada; Tina M Cowan; Miriam Aguilar; C Titus Brown; Danika L Bannasch
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

Review 2.  Epidemiology of Mucopolysaccharidoses Update.

Authors:  Betul Çelik; Saori C Tomatsu; Shunji Tomatsu; Shaukat A Khan
Journal:  Diagnostics (Basel)       Date:  2021-02-10

3.  Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes.

Authors:  Gretl Hendrickx; Tatyana Danyukova; Anke Baranowsky; Tim Rolvien; Alexandra Angermann; Michaela Schweizer; Johannes Keller; Jörg Schröder; Catherine Meyer-Schwesinger; Nicole Muschol; Chiara Paganini; Antonio Rossi; Michael Amling; Sandra Pohl; Thorsten Schinke
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

Review 4.  Diagnosis support systems for rare diseases: a scoping review.

Authors:  Carole Faviez; Xiaoyi Chen; Nicolas Garcelon; Antoine Neuraz; Bertrand Knebelmann; Rémi Salomon; Stanislas Lyonnet; Sophie Saunier; Anita Burgun
Journal:  Orphanet J Rare Dis       Date:  2020-04-16       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.